about
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceGlycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapySurgical and molecular pathology of pancreatic neoplasmsKRAS Mutant Pancreatic Cancer: No Lone Path to an Effective TreatmentTargeting hyaluronan for the treatment of pancreatic ductal adenocarcinomaPerioperative treatment options in resectable pancreatic cancer - how to improve long-term survivalGenetics and biology of pancreatic ductal adenocarcinomaRole of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlightVertebral Compression Fracture Related to Pancreatic Cancer With Osteoblastic Metastasis: A Case Report and Literature ReviewVarious diffusion magnetic resonance imaging techniques for pancreatic cancerFluorescent proteins as genetically encoded FRET biosensors in life sciencesPancreatic cancer surgery: past, present, and futureImproving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysisFunctional significance of macrophages in pancreatic cancer biologyEmerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)Pancreatic adenocarcinoma pathology: changing "landscape"Imaging preoperatively for pancreatic adenocarcinomaEndoscopic palliation of malignant biliary stricturesMolecular mechanism underlying lymphatic metastasis in pancreatic cancerGenetically engineered mouse models of pancreatic adenocarcinomaExploiting inflammation for therapeutic gain in pancreatic cancerInflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivoDuctal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancerPancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p.Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer.Minnelide, a novel drug for pancreatic and liver cancerHigh SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinomaGlycoproteins and glycoproteomics in pancreatic cancerSystematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic CancerIs it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?A current perspective on stereotactic body radiation therapy for pancreatic cancerEpidemiology of pancreatic cancerPrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisSerum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancersTargeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implicationsTranscriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesisA Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNAInhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabineLipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma
P2860
Q24622390-4CBEE8E8-47B1-45F1-8110-6FDE42EDBD4DQ26739711-180480BE-4E72-4A2C-B7F6-EBD18A03536EQ26748615-A438D8D2-3E39-483A-BB59-E6C7C636B966Q26751520-25893B80-6513-4DDD-8885-CF5EBE816BBCQ26752400-C893A808-690B-4FE4-9688-4ADAA808B969Q26753854-C872285B-4E92-4AFE-B862-BBEB7E18BB13Q26765438-AE2F52F9-6698-4C42-ACEB-1D2BB7546F29Q26766075-02696301-52D4-44A2-8F5E-C87F5ED4123DQ26769031-4B662B49-3A85-487C-9EA9-293F67C1122BQ26769804-71458328-07B6-4A4C-AC32-C6F2C5C39527Q26778988-3C86CF0F-0077-4FBC-AE5E-A1203E853F4DQ26781555-E4A1E001-D7AD-4CCF-95F5-BEDACBEA98E2Q26782719-03E41D4C-70B4-4667-B411-7A8A46FCC628Q26786515-34A535E5-0A15-47D4-AE08-4F7F4D3AFFF5Q26796523-EFF6E58A-3184-44B2-9AFA-1494550C8097Q26799446-AF793451-4C1E-44A6-98A7-F71FD23A52FDQ26799450-8EC1FB0A-E5AE-49E3-B97C-0F262B18363AQ26827619-52FDC4CD-4194-4601-B3D1-C00BB9FACA1FQ26999345-9D441EDE-D14F-4B0F-AB6E-B50754DB998AQ27002973-9CC4CC0E-BE9C-44AF-8DAF-CE99EDFA64DEQ27027661-333E3A3E-0DB5-4B8C-B21D-3EBD6C7BBE98Q27311572-5BA7496D-8AC1-4400-99B1-EB06B883B545Q27314878-8F0CB299-6CC1-4DE0-BEC9-71208B872366Q27334957-B03E109A-68EE-41F5-A2D8-AE88C7AB406BQ27340831-A0A3095D-A5F5-4EFC-AB98-4480D909B9AEQ27347648-41D81BE0-164B-43D0-B007-B5BC39544B76Q27693346-81BE40C9-B4CD-4BB6-AB1E-195DDC887E3BQ27852569-F62A99C5-9CDB-44C8-B10F-5FCDFAE778C2Q28071108-FD0C421F-FFF0-4BCA-9D57-BF749823035FQ28072210-925C935A-5BB1-4D6F-B37A-6AD86C3380CCQ28073673-64981C76-A576-4FA1-B231-F44D0917D790Q28077111-C65D16B0-AA6A-42F3-B716-3881011EDA98Q28079456-4B8C9184-4012-498E-886D-5313A64E9716Q28083684-CF25B7F1-ECC6-44E1-A2CD-66682EA282E9Q28254804-B2873F13-679C-4EA2-9A82-F7CAFE86A732Q28269990-C6E728D5-1178-401C-83F9-B87A6BFCF976Q28307924-3876708B-5501-4293-846B-D84ACB9CDF81Q28394647-D7A96D8E-E3C2-4D6C-9835-85C60D75F3C6Q28396251-B1993C1C-F878-4338-BD81-1421A8CC0592Q28484227-1DA33B75-7147-4B89-8C27-48B698D7F665
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im August 2011 veröffentlichter wissenschaftlicher Artikel
@de
scholarly article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2011
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Pancreatic Cancer
@en
Pancreatic cancer
@nl
type
label
Pancreatic Cancer
@en
Pancreatic cancer
@nl
prefLabel
Pancreatic Cancer
@en
Pancreatic cancer
@nl
P2860
P50
P1433
P1476
Pancreatic cancer
@en
P2093
Joseph Herman
Rich Schulick
P2860
P304
P356
10.1016/S0140-6736(10)62307-0
P407
P577
2011-08-13T00:00:00Z